Overview

Cardiac Arrhythmia Suppression Trial (CAST)

Status:
Completed
Trial end date:
1998-03-01
Target enrollment:
0
Participant gender:
All
Summary
To determine whether drug treatment of asymptomatic ventricular arrhythmias in post-myocardial infarction patients reduced the incidence of sudden cardiac death and total mortality.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Encainide
Flecainide
Moricizine
Criteria
Men and women with ventricular premature depolarization six days to two years after the
start of myocardial infarction.